Article by Caitlin Smith GEN: Genetic Engineering & Biotechnology, May 15, 2013 … Biovista has already repositioned two drugs for the progressive form of multiple sclerosis (MS), which has had few treatment options. Most MS drugs, for treatment of the relapsing-remitting form of MS, compromise the patients’ immune systems and have significant side effects. Biovista … Read More
News
VA BIOTECH – Concept to Commercialization
Biovista announces that its President, Dr. Aris Persidis, will participate in the “VA BIOTECH – Concept to Commercialization” Facebook event. About VA BIOTECH – Concept to Commercialization event: Charlottesville is home to some of the most cutting edge biotechnology firms in the Country. This panel, presented in partnership with U.Va. Innovation and Charlottesville Business Innovation … Read More
Biovista and DART Therapeutics Enter into Drug Repositioning Collaboration Targeting Duchenne Muscular Dystrophy
CHARLOTTESVILLE, Virginia and CAMBRIDGE, Massachusetts, March 26, 2013 /PRNewswire/ — DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy (DMD), and Biovista, a leader in systematic drug repositioning, announced today that they have entered into a research collaboration to identify and develop novel drug repositioning candidates for DMD … Read More
Biovista – NIH/DAIDS Seminar on use of MoA to predict Safety Signals
Biovista announces that its President, Dr. Aris Persidis, will give a seminar at the NIH/DAIDS Medical Officer’s Safety Forum on Thursday, March 28th. The seminar, is entitled “Using Mechanism of Action to Predict Safety Signals and Understanding Sub-Populations.” With the web being increasingly used to determine side effects of drugs, and with self-reporting patient social networking databases … Read More
Partnering for Cures – Biovista presentation
Presentation- CFIDS Association of America / Biovista View the joint presentation by Biovista President Dr. Aris Persidis and CFIDS’ Scientific Director, Dr. Suzanne Vernon at the 2012 Partnering for Cures conference. The collaboration between the CFIDS Association of America and Biovista leverages the accumulated knowledgebase for chronic fatigue syndrome (CFS) and Biovista’s state-of-the-art approaches to … Read More